To establish the safety threshold using the NI approach, one must determine the maximum acceptable increase in outcome incidence associated with the drug of interest that would not lead to subsequent action. This tolerable difference can be stated in relation to
either the comparator or no treatment and on either ratio or difference scales. If framed would be relative to the comparator, the stated difference